Mitral valve prolapse in hyperthyroidism of two different origins

Area of Science:

• Cardiology
• Endocrinology
• Thyroid Disorders

Background:

• Hyperthyroidism, particularly Graves' disease, can affect cardiovascular function.
• Mitral valve prolapse (MVP) is a common cardiac condition with varying prevalence.
• The relationship between hyperthyroidism and MVP requires further investigation.

Purpose of the Study:

• To determine the prevalence of mitral valve prolapse in patients with hyperthyroidism.
• To assess the prevalence of hyperthyroidism in patients with mitral valve prolapse.
• To compare the prevalence of MVP in Graves' disease and toxic nodular goitre patients with a control group.

Main Methods:

• Cross-sectional study comparing patient groups and a control cohort.
• Inclusion criteria: 126 hyperthyroid patients (Graves' disease or toxic nodular goitre) and 64 MVP patients.
• Control group: 111 asymptomatic healthy subjects.

Main Results:

• Overall prevalence of MVP in hyperthyroid patients (9.5%) was not significantly higher than in controls (5.4%).
• Prevalence of MVP in toxic nodular goitre patients was similar to controls.
• Significantly higher prevalence of MVP was observed in Graves' disease patients (16.3%) compared to controls (5.4%).
• Only one MVP patient presented with hyperthyroidism.

Conclusions:

• Graves' disease is associated with a significantly increased prevalence of mitral valve prolapse.
• Hyperthyroidism, in general, and toxic nodular goitre specifically, do not show a significant association with mitral valve prolapse.
• Further research is warranted to elucidate the specific mechanisms linking Graves' disease and MVP.